BOT 2.70% 36.0¢ botanix pharmaceuticals ltd

Ann: FDA Letter Requires Patient Instruction Update, page-14

  1. 3,255 Posts.
    lightbulb Created with Sketch. 785
    Honestly not fussed in the slightest by this - in the next 3 - 6 months we will get further results around Kaken sales in Japan and soon Korea too. We will likely see in our quarterly's income grow and then the confirmation of FDA approval.

    This basically reads like "we're approved! we just f*ed up a word or two on how the customer needs to apply this shit which isn't a major red flag - See you in 3 - 6 months"
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
36.0¢
Change
-0.010(2.70%)
Mkt cap ! $651.6M
Open High Low Value Volume
37.0¢ 37.0¢ 35.5¢ $1.156M 3.204M

Buyers (Bids)

No. Vol. Price($)
19 298180 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 246560 11
View Market Depth
Last trade - 13.51pm 19/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.